NOXA as critical mediator for drug combinations in polychemotherapy

por Ehrhardt, H, Höfig, I, Wachter, F, Obexer, P, Fulda, S, Terziyska, N, Jeremias, I
Publicado 2012

MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion

por Falkenberg, N, Anastasov, N, Rappl, K, Braselmann, H, Auer, G, Walch, A, Huber, M, Höfig, I, Schmitt, M, Höfler, H, Atkinson, M J, Aubele, M
Publicado 2013